FSGS and NS Research Funding Opportunities Through PRMRP

Published on April 27, 2024
FSGS and NS Research Funding Opportunities Through PRMRP

The US Department of Defense includes FSGS and nephrotic syndrome as two of the priority research areas targeted for funding in 2024 under its $370 million Peer-Reviewed Medical Research Program, known as PRMRP. Researchers in the US as well as internationally are eligible to apply for grants across various categories of basic, translational, and clinical research. This year's deadlines are approaching, beginning in early May!

Continue reading on website
Other news

Episode 5: Industry Perspective with Jula Inrig: Endothelin Antagonism, IgAN, FSGS, Clinical Trial Career Paths, and the New Era of Nephrology Trials

April 26, 2024
In this episode, Kenar and Koyal talk with Dr. Jula Inrig about endothelin physiology and different approaches to endothelin antagonism, trials of sparsentan in IgAN and FSGS, the art and science of clinical trial design, career paths in clinical research outside academia, and how we got to our current era of plentiful nephrology clinical trials.Disclosure: Jula Inrig is the Chief Medical Officer

Episode 6: Astrid Weins on Anti-Nephrin Antibodies and Nephropathology

May 17, 2024
In this episode, Kenar and Koyal interview Dr. Astrid Weins, MD, PhD, about nephropathology, new approaches to solving the mysteries of nephrotic syndrome, and her research on anti-nephrin antibodies in minimal change disease. Dr. Weins is Chief of Integrated Renal Pathology at Mass General/Brigham and an Assistant Professor of Pathology at Harvard.Interested in this topic? Stay tuned for addition